Brought to you by 
Investment group scoops up Arbor Pharmaceuticals
30 Apr 2010
Executive Summary
Pediatric-focused specialty pharmaco Arbor Pharmaceuticals Inc. has been acquired by an investment group led by Jason Wild of JW Asset Management and Edward Schutter, former president and COO of Sciele Pharma (now Shionogi Pharma).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Investment group scoops up Arbor Pharmaceuticals
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice